Beilu Pharma(SZ:300016) Xin Lang Cai Jing·2025-10-29 02:17Core Insights - Northland Pharmaceutical (300016.SZ) released its Q3 2025 report, indicating a total of 52.656 million A-shares held by three institutional investors, accounting for 9.35% of the company's total share capital [1] Institutional Holdings - The total institutional holding percentage decreased by 2.44 percentage points compared to the previous quarter [1] - The institutional investors include Chongqing Three Gorges Paint Co., Ltd., China Resources Yukun Asset Management Co., Ltd., and Guolian Medical Health Mixed A [1] Public Fund Holdings - One public fund, Guolian Medical Health Mixed A, reported a slight decrease in holdings compared to the previous quarter [1] - Ten public funds that did not disclose holdings this quarter include notable names such as PICC Trend Selection Mixed A, Wanji Entrepreneur Board Comprehensive ETF, and Southern CSI 2000 ETF [1] Foreign Investment - Several foreign institutions, including BARCLAYS BANK PLC, MORGAN STANLEY & CO. INTERNATIONAL PLC, and Goldman Sachs LLC, did not disclose their holdings this quarter [1]